title: Phytoestrogens are partial estrogen agonists in the adult male mouse.
abstract: The intake, as well as serum and urinary concentrations, of phytoestrogens is high in countries where incidence of prostate cancer is low, suggesting a chemopreventive role for phytoestrogens. Their significance could be explained by the ability to antagonize the action of more potent endogenous estrogens in initiation or promotion of tumor formation. We have studied estrogenicity and antiestrogenicity of dietary soy and two phytoestrogens, coumestrol and daidzein, in our neoDES mouse model for the study or prostatic neoplasia. Soy was chosen because it is rich in phytoestrogens, is widely used in Oriental diets, and has antiestrogenic and anticarcinogenic properties in the neoDES mouse when given from fertilization onward. In short-term tests with adult animals, no evidence for estrogenicity or antiestrogenicity (capability to antagonize the action of 17 beta-estradiol) of soy was found when development of epithelial metaplasia and expression of c-fos protooncogene in prostate were used as end points of estrogen action. Estrogenic activity of coumestrol and daidzein on c-fos expression was subtle. Coumestrol, either given alone or in combination with 17 beta-estradiol, had no effect on development of epithelial metaplasia. These marginal or missing effects in adult males could be interpreted by assuming that the neonatal period is more critical for estrogenic or antiestrogenic action of soy and phytoestrogens. Once initiated, estrogen-related lesions would develop spontaneously. Alternatively, the chemopreventive action of soy is not due to antiestrogenicity of soy-derived phytoestrogens.
authors.affiliation: Institute of Biomedicine and Medicity Research Laboratory, University of Turku, Finland.
authors.forename: S
authors.initials: S
authors.lastname: Mäkelä
authors.forename: R
authors.initials: R
authors.lastname: Santti
authors.forename: L
authors.initials: L
authors.lastname: Salo
authors.forename: J A
authors.initials: JA
authors.lastname: McLachlan
mesh_terms: D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D003375:Coumestrol / Q000494:pharmacology; D004032:Diet; D004054:Diethylstilbestrol / Q000633:toxicity*; D004195:Disease Models, Animal; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D004968:Estrogens, Non-Steroidal / Q000494:pharmacology; D007529:Isoflavones / Q000494:pharmacology; D008297:Male; D008679:Metaplasia / Q000139:chemically induced; D051379:Mice; D010937:Plant Growth Regulators / Q000494:pharmacology*; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis; D011960:Receptors, Estrogen / Q000819:agonists*; D013025:Glycine max
chemical_list: D016588:Anticarcinogenic Agents; D004967:Estrogens; D004968:Estrogens, Non-Steroidal; D007529:Isoflavones; D010937:Plant Growth Regulators; D016760:Proto-Oncogene Proteins c-fos; D011960:Receptors, Estrogen; D004958:Estradiol; C004742:daidzein; D004054:Diethylstilbestrol; D003375:Coumestrol